MedTrace Logo

Application for Arts-Based Social Prescribing

NCT07593443 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.

The main question it aims to answer is:

Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.

Participants will:

Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.

Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).

If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.

Conditions

  • Depression in Adolescence
  • Anxiety
  • Loneliness
  • Social Connectedness

Interventions

BEHAVIORAL

Art Pharmacy

A personalized arts-based social prescribing program

OTHER

Stable treatment

Stable treatment (no change to existing care) through Medicaid managed care

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Boston College

    collaborator OTHER

  • SocialRx Inc

    lead INDUSTRY

Principal Investigators

  • Dawn McDaniel, PhD · SocialRx Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-01-31
Completion
2028-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07593443 on ClinicalTrials.gov